Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    ISS01 - Industry Supported Symposium: Current and Emerging Treatments for Patients with ALK+ NSCLC – ARIAD Pharmaceuticals Inc.

    • Type: Industry Supported Symposium
    • Track:
    • Presentations: 5
    • Moderators:C. Zielinski
    • Coordinates: 12/04/2016, 12:00 - 13:30, Strauss 3
    • +

      ISS01.01 - Welcome & Introduction

      12:00 - 12:05  |  Author(s): C. Zielinski

      • Abstract

      No abstract available for this presentation

    • +

      ISS01.02 - ALK Inhibitors: Current Treatments and Sequencing

      12:05 - 12:30  |  Author(s): C. Zielinski

      • Abstract

      No abstract available for this presentation

    • +

      ISS01.03 - The Future of ALK Inhibitors: How the Treatment Paradigm May Change

      12:30 - 12:55  |  Author(s): D..R. Camidge

      • Abstract

      No abstract available for this presentation

    • +

      ISS01.04 - Will Mutation Testing be Standard in the Resistant Setting?

      12:55 - 13:20  |  Author(s): P. Jänne

      • Abstract

      No abstract available for this presentation

    • +

      ISS01.05 - Summary and Conclusions

      13:20 - 13:30  |  Author(s): C. Zielinski

      • Abstract

      No abstract available for this presentation

  • +

    SC14 - Immunotherapy of NSCLC

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:N. Rizvi
    • Coordinates: 12/06/2016, 11:00 - 12:30, Hall C2
  • +

    SC22 - Selection and Monitoring of Patients for Immune Checkpoint Inhibitors

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:G.V. Scagliotti
    • Coordinates: 12/06/2016, 16:00 - 17:30, Hall C8
  • +

    PR04 - Press Conference: Advanced Care

    • Type: Press Conference
    • Track:
    • Presentations: 5
    • Moderators:C. Zielinski
    • Coordinates: 12/07/2016, 10:30 - 11:45, Schubert 1
    • +

      PR04.01 - Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024

      10:30 - 10:30  |  Author(s): J.R. Brahmer

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR04.02 - OAK, a Randomized Ph III Study of Atezolizumab vs Docetaxel in Patients with Advanced NSCLC: Results from Subgroup Analyses

      10:30 - 10:30  |  Author(s): S.M. Gadgeel

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR04.03 - Durvalumab in ≥3rd-Line Locally Advanced or Metastatic, EGFR/ALK Wild-Type NSCLC: Results from the Phase 2 ATLANTIC Study

      10:30 - 10:30  |  Author(s): M.C. Garassino

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR04.04 - Multicentric French Harmonization Study for PD-L1 IHC Testing in NSCLC

      10:30 - 10:30  |  Author(s): J. Adam

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      PR04.05 - A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): With Translational Research (TR) Biopies

      10:30 - 10:30

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.